Search

Your search keyword '"Holkova, Beata"' showing total 10 results
Start Over Author "Holkova, Beata" Publication Year Range Last 3 years
10 results on '"Holkova, Beata"'

2. Supplementary Table 2 from A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2

Author

Holkova, Beata, primary, Supko, Jeffrey G., primary, Ames, Matthew M., primary, Reid, Joel M., primary, Shapiro, Geoffrey I., primary, Perkins, Edward Brent, primary, Ramakrishnan, Viswanathan, primary, Tombes, Mary Beth, primary, Honeycutt, Connie, primary, McGovern, Renee M., primary, Kmieciak, Maciej, primary, Shrader, Ellen, primary, Wellons, Martha D., primary, Sankala, Heidi, primary, Doyle, Austin, primary, Wright, John, primary, Roberts, John D., primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table 3 from A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2

Author

Holkova, Beata, primary, Supko, Jeffrey G., primary, Ames, Matthew M., primary, Reid, Joel M., primary, Shapiro, Geoffrey I., primary, Perkins, Edward Brent, primary, Ramakrishnan, Viswanathan, primary, Tombes, Mary Beth, primary, Honeycutt, Connie, primary, McGovern, Renee M., primary, Kmieciak, Maciej, primary, Shrader, Ellen, primary, Wellons, Martha D., primary, Sankala, Heidi, primary, Doyle, Austin, primary, Wright, John, primary, Roberts, John D., primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table 1 from A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2

Author

Holkova, Beata, primary, Supko, Jeffrey G., primary, Ames, Matthew M., primary, Reid, Joel M., primary, Shapiro, Geoffrey I., primary, Perkins, Edward Brent, primary, Ramakrishnan, Viswanathan, primary, Tombes, Mary Beth, primary, Honeycutt, Connie, primary, McGovern, Renee M., primary, Kmieciak, Maciej, primary, Shrader, Ellen, primary, Wellons, Martha D., primary, Sankala, Heidi, primary, Doyle, Austin, primary, Wright, John, primary, Roberts, John D., primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Methods from A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2

Author

Holkova, Beata, primary, Supko, Jeffrey G., primary, Ames, Matthew M., primary, Reid, Joel M., primary, Shapiro, Geoffrey I., primary, Perkins, Edward Brent, primary, Ramakrishnan, Viswanathan, primary, Tombes, Mary Beth, primary, Honeycutt, Connie, primary, McGovern, Renee M., primary, Kmieciak, Maciej, primary, Shrader, Ellen, primary, Wellons, Martha D., primary, Sankala, Heidi, primary, Doyle, Austin, primary, Wright, John, primary, Roberts, John D., primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Materials from Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-cell Neoplasms

Author

Holkova, Beata, primary, Kmieciak, Maciej, primary, Perkins, E. Brent, primary, Bose, Prithviraj, primary, Baz, Rachid C., primary, Roodman, G. David, primary, Stuart, Robert K., primary, Ramakrishnan, Viswanathan, primary, Wan, Wen, primary, Peer, Cody J., primary, Dawson, Jana, primary, Kang, Loveleen, primary, Honeycutt, Connie, primary, Tombes, Mary Beth, primary, Shrader, Ellen, primary, Weir-Wiggins, Caryn, primary, Wellons, Martha, primary, Sankala, Heidi, primary, Hogan, Kevin T., primary, Colevas, A. Dimitrios, primary, Doyle, L. Austin, primary, Figg, William D., primary, Coppola, Domenico, primary, Roberts, John D., primary, Sullivan, Daniel, primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Data from Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory B-Cell Neoplasms

Author

Holkova, Beata, primary, Perkins, E. Brent, primary, Ramakrishnan, Viswanathan, primary, Tombes, Mary Beth, primary, Shrader, Ellen, primary, Talreja, Neha, primary, Wellons, Martha D., primary, Hogan, Kevin T., primary, Roodman, G. David, primary, Coppola, Domenico, primary, Kang, Loveleen, primary, Dawson, Jana, primary, Stuart, Robert K., primary, Peer, Cody, primary, Figg, William D., primary, Kolla, Sarah, primary, Doyle, Austin, primary, Wright, John, primary, Sullivan, Daniel M., primary, Roberts, John D., primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

8. Synergistic effects of low-dose belantamab mafodotin in combination with a gamma-secretase inhibitor (nirogacestat) in patients with relapsed/refractory multiple myeloma (RRMM): DREAMM-5 study.

Author

Lonial, Sagar, primary, Grosicki, Sebastian, additional, Hus, Marek, additional, Song, Kevin W., additional, Facon, Thierry, additional, Callander, Natalie Scott, additional, Ribrag, Vincent, additional, Uttervall, Katarina, additional, Quach, Hang, additional, Vorobyev, Vladimir I., additional, Min, Chang Ki, additional, Cheng, Shinta, additional, Smith, L. Mary, additional, Yu, Jing, additional, Collingwood, Therese, additional, Holkova, Beata, additional, Kremer, Brandon, additional, Gupta, Ira, additional, Richardson, Paul G., additional, and Minnema, Monique C., additional

Published
2022
Full Text
View/download PDF

9. DREAMM-5 Study: Investigating the Synergetic Effects of Belantamab Mafodotin Plus Inducible T-Cell Co-Stimulator Agonist (aICOS) Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma

Author

Callander, Natalie S., primary, Ribrag, Vincent, additional, Richardson, Paul G., additional, Nooka, Ajay K., additional, Song, Kevin, additional, Uttervall, Katarina, additional, Minnema, Monique C., additional, Weisel, Katja, additional, Quach, Hang, additional, Min, Chang-Ki, additional, Ballas, Marc S., additional, Li, Xiaofang, additional, Ratia, Nirav, additional, Kaisermann, Morrys, additional, Holkova, Beata, additional, and Trudel, Suzanne, additional

Published
2021
Full Text
View/download PDF

10. P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM)

Author

Richardson, Paul G., primary, Trudel, Suzanne, additional, Callander, Natalie S., additional, Nooka, Ajay, additional, Song, Kevin, additional, Uttervall, Katarina, additional, Minnema, Monique C., additional, Rodríguez-Otero, Paula, additional, Struemper, Herbert, additional, Yeakey, Anne, additional, de Oca, Rocio Montes, additional, Smith, L. Mary, additional, Jackson, Nicola, additional, Kaisermann, Morrys, additional, Im, Ellie, additional, Basile, Frank G., additional, Ahlers, Christoph M., additional, Holkova, Beata, additional, Gupta, Ira, additional, Kremer, Brandon E., additional, and Quach, Hang, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results